GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $140.80 $156.84 Wednesday, 17th Apr 2024 ASND stock ended at $142.17. This is 0.473% more than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 2.45% from a day low at $140.80 to a day high of $144.25.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
2021-12-30 $132.95 $139.93 $132.76 $136.41 132 297
2021-12-29 $134.16 $136.73 $131.05 $133.75 115 539
2021-12-28 $138.46 $140.12 $133.41 $134.68 119 820
2021-12-27 $136.93 $139.60 $135.80 $138.46 102 020
2021-12-23 $139.50 $140.14 $134.82 $139.32 97 537
2021-12-22 $138.24 $143.09 $137.41 $139.03 194 720
2021-12-21 $135.12 $140.63 $134.82 $138.64 219 022
2021-12-20 $130.63 $137.17 $128.93 $134.39 206 619
2021-12-17 $125.83 $133.24 $125.00 $132.39 355 265
2021-12-16 $134.13 $138.81 $127.10 $127.10 529 215
2021-12-15 $136.64 $138.05 $131.15 $134.15 492 386
2021-12-14 $139.33 $142.38 $136.20 $136.64 263 108
2021-12-13 $139.99 $144.25 $137.91 $140.11 278 887
2021-12-10 $140.71 $142.82 $138.30 $140.00 303 815
2021-12-09 $146.35 $147.86 $139.22 $139.65 131 657
2021-12-08 $144.39 $147.90 $140.13 $146.03 259 800
2021-12-07 $138.91 $145.48 $138.91 $142.95 211 797
2021-12-06 $135.00 $139.91 $131.91 $136.64 197 538
2021-12-03 $145.06 $145.69 $133.05 $135.61 402 074
2021-12-02 $141.48 $146.54 $140.64 $145.89 165 042
2021-12-01 $138.34 $144.98 $135.52 $141.62 312 901
2021-11-30 $141.20 $144.96 $136.16 $137.02 372 517
2021-11-29 $145.39 $145.82 $140.86 $141.19 189 701
2021-11-26 $145.96 $147.97 $141.49 $143.82 81 307
2021-11-24 $148.21 $148.74 $144.14 $147.39 113 169
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT